查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1954652

全球肺活量计市场：市场规模、占有率、成长率、行业分析、依类型、应用和地区划分的分析以及未来预测（2026-2034 年）

Spirometers Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 139 Pages | 商品交期: 请询问到货日

价格

肺活量计市场成长驱动因子

2025 年，全球肺活量计（肺容量计）市值为 6.7985 亿美元。预计该市场将从 2026 年的 7.1661 亿美元增长到 2034 年的 11.2292 亿美元，在预测期（2026-2034 年）内复合年增长率 (CAGR) 为 6.63%。

2025 年，北美地区占肺活量计市场的主导地位，市占率为 50.46%，这得益于该地区呼吸系统疾病的高发生率和完善的医疗保健基础设施。

肺活量计是一种诊断医疗设备，透过测量吸入和呼出的气体量来评估肺功能。 呼出气量。 肺功能测定在气喘、慢性阻塞性肺病 (COPD) 和囊性纤维化等呼吸系统疾病的诊断和治疗中发挥着至关重要的作用。根据国际呼吸学会论坛 (2023) 的数据，全球约有 3.34 亿人患有气喘，超过 6,500 万人患有 COPD，凸显了对肺功能测定设备日益增长的需求。

由于肺功能检测 (PFT) 机构的暂时关闭，COVID-19 疫情对市场造成了负面影响，但随着医疗机构的重新开放和呼吸系统诊断需求的增加，市场在 2021 年至 2022 年间开始復苏。

肺功能测定仪市场趋势

智慧型互联设备投资增加

对数位健康和​​互联肺功能测定解决方案的投资增加正在推动市场成长。 各公司正在开发支援蓝牙连接、整合人工智慧的肺活量计，用于远端监测。

例如，2023年1月，Aluna 获得了1530万美元的B轮融资，用于扩展其应用程式连接的肺活量计解决方案，以用于气喘、慢性阻塞性肺病和囊性纤维化管理。同样，Clario 和 ArtiQ 等公司于2023年3月达成的合作，正在加强人工智慧驱动的肺活量计数据分析在临床试验中的应用。

智慧肺活量计的引进已被证实可以减少气喘相关的急诊就诊和住院次数，从而进一步增强了产品需求。

市场成长驱动因素

加速技术进步

技术创新是成长的主要驱动力。便携式、手持式和用户友好的肺活量计设备解决了利用率低的问题。 2020年1月，NuvoAir的连网肺活量计获得美国FDA核准，实现了远端肺功能监测。

人工智慧（AI）的整合进一步提高了诊断准确性并优化了治疗方案。持续的研发投入可望改善慢性阻塞性肺病（COPD）的早期检测和疾病管理效果。

COPD发生率呈上升趋势

COPD是全球第三大死因。根据美国国家心肺血液研究所（2022年）统计，约有1,600万美国人患有COPD。吸烟、污染和环境暴露是主要致病因素。全球呼吸系统疾病负担的加重显着推高了肺活量测定的需求。

限制因子

熟练专业人员短缺

一个主要的限制因素是训练有素的肺功能测试人员短缺。 根据世界卫生组织（WHO，2023）的预测，到2030年，全球可能出现1000万医护人员的缺口，尤其是在低收入国家。发展中地区熟练劳动力短缺和医疗意识薄弱可能是设备普及应用的障碍。

细分市场分析

依产品类型

该市场依产品类型细分为设备、软体和配件/耗材。

  • 设备细分市场占最大占有率，达52.75%，这主要得益于对先进诊断设备需求的成长。
  • 由于数位医疗的普及，软体细分市场预计将显着成长。
  • 由于设备零件可重复使用，配件/耗材的需求保持稳定。

依类型

此市场依类型分为容积式肺活量计和峰值流量计。

  • 预计到 2026 年，容积式肺活量计市占率将达到 47.71%，这主要得益于其测量结果的准确性和广泛的临床应用。
  • 由于无线和便携式解决方案的日益普及，峰值流量计的市场占有率也在增长。

依应用

应用领域包括慢性阻塞性肺病 (COPD)、气喘和其他疾病。

  • 预计到 2026 年，COPD 应用领域市占率将达到 45.38%，主要得益于该疾病盛行率的上升。
  • 气喘仍然是一个主要因素，尤其是在儿童。

依最终使用者划分

市场依最终用户划分为医院、诊断中心、家庭医疗保健、诊所和其他。

  • 预计到 2026 年，医院细分市场将占 35.34% 的市场占有率，这主要得益于医疗保健支出的成长。
  • 由于患者对远端监测解决方案的偏好，家庭医疗保健细分市场正呈现快速成长。

区域洞察

北美

预计到 2025 年，北美市场规模将达到 3.4307 亿美元，占 50.46% 的主导占有率。慢性阻塞性肺病 (COPD) 和气喘的高发病率、强有力的监管支持以及主要厂商的存在，正在推动该地区的成长。 预计2026年，美国市场规模将达到3.2453亿美元。

欧洲

由于认知度提高和监管审批的推进，欧洲市场预计将稳定成长。预计2026年，英国市场规模将达3,773万美元，德国市场规模将达2,412万美元。

亚太地区

由于投资增加和产品发布，预计亚太地区将实现强劲成长。 预计2026年，日本市场规模将达到1,940万美元，中国市场规模将达到2,685万美元，印度市场规模将达到2,508万美元。

世界其他地区

拉丁美洲和中东及非洲地区的市场占有率相对较小，但正在透过培训计画和宣传活动不断改善。

目录

第一章 引言

第二章 摘要整理

第三章 市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机遇
  • 市场趋势

第四章 主要发现

  • 主要国家和地区呼吸系统疾病盛行率（2025 年）
  • 主要公司新产品发布
  • 主要产业趋势－併购与合作
  • 主要国家和地区的监管状况
  • 肺活量计相关技术进步
  • 远端肺活量测定－定性和定量洞察
  • 新冠疫情对市场的影响

第五章 全球肺活量计市场分析：洞察与预测（2021-2034）

  • 市场分析、洞察与预测：依产品类型划分
    • 设备
    • 软体
    • 配件和耗材
  • 市场分析、洞察与预测：依类型划分
    • 容积测量
    • 峰值流量计
  • 市场分析、洞察与预测：依应用划分
    • 慢性阻塞性肺病 (COPD)
    • 气喘
    • 其他
  • 市场分析、洞察与预测：依最终用户划分
    • 医院
    • 诊断中心
    • 家庭医疗保健
    • 医生/初级保健诊所
    • 其他机构
  • 市场分析、洞察与预测：依地区划分
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第六章 北美肺活量计市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 美国
    • 加拿大

第七章 欧洲肺活量计市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 美国王国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 斯堪的纳维亚
    • 其他欧洲地区

第八章 亚太地区肺活量计市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 日本
    • 中国
    • 印度
    • 澳大利亚
    • 东南亚
    • 其他亚太地区

第九章 拉丁美洲肺活量计市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 巴西
    • 墨西哥
    • 其他拉丁美洲国家

第十章 分析中东与非洲肺活量计市场：洞察与预测（2021-2034）

  • 各国市场分析
    • 海湾合作委员会 (GCC)
    • 南非
    • 其他中东和非洲国家

第11章 竞争分析

  • 全球市占率分析（2025）
  • 公司简介
    • ndd Medizintechnik AG
    • COSMED srl
    • MGC Diagnostics Corporation
    • Morgan Scientific
    • Chest M.I., Inc.
    • VYAIRE
    • Ganshorn Medizin Electronic GmbH
    • Medical International Research (MIR)
Product Code: FBI100486

Growth Factors of spirometer Market

The global spirometer market size was valued at USD 679.85 million in 2025. The market is projected to grow from USD 716.61 million in 2026 to USD 1,122.92 million by 2034, exhibiting a CAGR of 6.63% during the forecast period (2026-2034).

North America dominated the spirometer market with a 50.46% market share in 2025, supported by high respiratory disease prevalence and strong healthcare infrastructure.

A spirometer is a diagnostic medical device used to measure lung function by assessing the volume of air inhaled and exhaled. It plays a crucial role in diagnosing and managing respiratory disorders such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. According to the Forum of International Respiratory Societies (2023), around 334 million people suffer from asthma globally, and more than 65 million people are affected by COPD, highlighting the growing demand for spirometry devices.

Although the COVID-19 pandemic negatively impacted the market due to temporary closures of pulmonary function testing (PFT) labs, recovery began in 2021-2022 with the reopening of healthcare facilities and rising demand for respiratory diagnostics.

SPIROMETER MARKET TRENDS

Growing Investment in Smart and Connected Devices

Rising investments in digital health and connected spirometry solutions are driving market growth. Companies are developing Bluetooth-enabled and AI-integrated spirometers for remote monitoring.

For instance, in January 2023, Aluna secured USD 15.3 million in Series B funding to expand its app-connected spirometry solution for asthma, COPD, and cystic fibrosis management. Similarly, partnerships such as Clario and ArtiQ (March 2023) are enhancing AI-driven spirometry data analysis in clinical trials.

The adoption of smart spirometers has shown a reduction in emergency visits and hospitalizations related to asthma, further strengthening product demand.

MARKET GROWTH FACTORS

Increasing Technological Advancements

Technological innovation is a key growth driver. Portable, handheld, and user-friendly spirometry devices have addressed underutilization challenges. In January 2020, NuvoAir's connected spirometer received FDA approval in the U.S., enabling remote lung monitoring.

Artificial intelligence integration is further improving diagnostic accuracy and treatment optimization. Continuous R&D investments are expected to support early COPD detection and improve disease management outcomes.

Rising Prevalence of COPD

COPD is the third leading cause of death worldwide. According to the National Heart, Lung, and Blood Institute (2022), approximately 16 million Americans suffer from COPD. Smoking, pollution, and environmental exposures are major contributors. The growing global burden of respiratory diseases is significantly boosting demand for spirometry testing.

RESTRAINING FACTORS

Shortage of Skilled Professionals

A major limitation is the shortage of trained pulmonary function technologists. According to WHO (2023), there could be a shortfall of 10 million healthcare workers by 2030, particularly in low-income countries. Limited skilled workforce and lack of awareness in developing regions may restrict device adoption.

SEGMENTATION ANALYSIS

By Product Type

The market is segmented into devices, software, and accessories & consumables.

  • The devices segment dominated with a 52.75% share, driven by increasing demand for advanced diagnostic equipment.
  • The software segment is expected to grow significantly due to digital health adoption.
  • Accessories & consumables maintain steady demand due to reusable device components.

By Type

The market includes volume measurement spirometers and peak flow meters.

  • The volume measurement segment held 47.71% share in 2026, owing to accurate results and wide clinical applications.
  • Peak flow meters are growing due to increasing availability of wireless and portable solutions.

By Application

Segments include COPD, asthma, and others.

  • The COPD segment accounted for 45.38% share in 2026, driven by increasing disease prevalence.
  • Asthma remains a major contributor, especially among children.

By End User

The market is segmented into hospitals, diagnostic centers, homecare settings, clinics, and others.

  • The hospitals segment is projected to hold 35.34% share in 2026, supported by rising healthcare expenditure.
  • Homecare settings are witnessing rapid growth due to patient preference for remote monitoring solutions.

REGIONAL INSIGHTS

North America

North America recorded a market size of USD 343.07 million in 2025 and held a dominant 50.46% share. High COPD and asthma prevalence, strong regulatory support, and presence of major players drive regional growth. The U.S. market is projected to reach USD 324.53 million in 2026.

Europe

Europe is projected to grow steadily due to increasing awareness and regulatory approvals. The UK market is projected to reach USD 37.73 million in 2026, while Germany is expected to reach USD 24.12 million in 2026.

Asia Pacific

Asia Pacific is anticipated to witness strong growth due to increasing investments and product launches. The Japan market is projected to reach USD 19.4 million in 2026, China USD 26.85 million, and India USD 25.08 million.

Rest of the World

Latin America and the Middle East & Africa hold comparatively smaller shares but are improving through training programs and awareness campaigns.

COMPETITIVE LANDSCAPE

Key companies include ndd Medizintechnik AG, COSMED srl, MGC Diagnostics, Morgan Scientific, VYAIRE, Ganshorn, and MIR. Strategic collaborations, acquisitions, and AI integration initiatives are strengthening competitive positioning. For example, CAIRE Inc. acquired MGC Diagnostics in January 2023 to expand its respiratory diagnostics portfolio.

CONCLUSION

The global spirometer market is set to grow steadily from USD 679.85 million in 2025 to USD 716.61 million in 2026, reaching USD 1,122.92 million by 2034 at a CAGR of 6.63%. Growth is primarily driven by the increasing prevalence of COPD and asthma, technological advancements in portable and AI-enabled spirometry devices, and expanding home healthcare adoption.

North America remains the leading region with a 50.46% share in 2025, while Asia Pacific is emerging as a high-growth market. Although workforce shortages and limited awareness in developing countries pose challenges, rising investments, regulatory support, and digital health integration are expected to unlock long-term opportunities.

Segmentation By Product Type

  • Devices
  • Software
  • Accessories & Consumables

By Type

  • Volume Measurement
  • Peak Flow Meters

By Application

  • Chronic Obstructive Pulmonary Disorder (COPD)
  • Asthma
  • Others

By End User

  • Hospitals
  • Diagnostic Centers
  • Homecare Settings
  • Physician/Primary Care Offices or Clinics
  • Other Facilities

By Region

  • North America (By Product Type, By Type, By Application, By End-User, By Country)
    • U.S. (By Type)
    • Canada (By Type)
  • Europe (By Product Type, By Type, By Application, By End-User, By Country/Sub-Region)
    • U.K. (By Type)
    • Germany (By Type)
    • France (By Type)
    • Italy (By Type)
    • Spain (By Type)
    • Scandinavia (By Type)
    • Rest of Europe (By Type)
  • Asia Pacific (By Product Type, By Type, By Application, By End User, By Country/Sub-Region)
    • Japan (By Type)
    • China (By Type)
    • India (By Type)
    • Australia (By Type)
    • Southeast Asia (By Type)
    • Rest of the Asia Pacific (By Type)
  • Latin America (By Product Type, By Type, By Application, By End User, By Country/Sub-Region)
    • Brazil (By Type)
    • Mexico (By Type)
    • Rest of Latin America (By Type)
  • Middle East & Africa (By Product Type, By Type, By Application, By End User, By Country/Sub-Region)
    • GCC (By Type)
    • South Africa (By Type)
    • Rest of the Middle East & Africa (By Type)

Table of Content

1. Introduction

  • 1.1. Market Scope
  • 1.2. Market Segmentation
  • 1.3. Market Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Respiratory Disorders, By Key Countries/Regions, 2025
  • 4.2. New Product Launches, By Key Players
  • 4.3. Key Industry Developments - Mergers, Acquisitions, and Partnerships
  • 4.4. Regulatory Scenario, By Key Countries/Regions
  • 4.5. Technological Advancements Pertaining to Spirometer
  • 4.6. Telespirometry - Qualitative and Quantitative Insights
  • 4.7. Impact of COVID-19 on the Market

5. Global Spirometer Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Product Type
    • 5.1.1. Devices
    • 5.1.2. Software
    • 5.1.3. Accessories & Consumables
  • 5.2. Market Analysis, Insights and Forecast - By Type
    • 5.2.1. Volume Measurement
    • 5.2.2. Peak Flow Meters
  • 5.3. Market Analysis, Insights and Forecast - By Application
    • 5.3.1. Chronic Obstructive Pulmonary Disorder (COPD)
    • 5.3.2. Asthma
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By End User
    • 5.4.1. Hospitals
    • 5.4.2. Diagnostic Centers
    • 5.4.3. Homecare Settings
    • 5.4.4. Physician/Primary Care Offices or Clinics
    • 5.4.5. Other Facilities
  • 5.5. Market Analysis, Insights and Forecast - By Region
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa

6. North America Spirometer Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product Type
    • 6.1.1. Devices
    • 6.1.2. Software
    • 6.1.3. Accessories & Consumables
  • 6.2. Market Analysis, Insights and Forecast - By Type
    • 6.2.1. Volume Measurement
    • 6.2.2. Peak Flow Meters
  • 6.3. Market Analysis, Insights and Forecast - By Application
    • 6.3.1. Chronic Obstructive Pulmonary Disorder (COPD)
    • 6.3.2. Asthma
    • 6.3.3. Others
  • 6.4. Market Analysis, Insights and Forecast - By End User
    • 6.4.1. Hospitals
    • 6.4.2. Diagnostic Centers
    • 6.4.3. Homecare Settings
    • 6.4.4. Physician/Primary Care Offices or Clinics
    • 6.4.5. Other Facilities
  • 6.5. Market Analysis, Insights and Forecast - By Country
    • 6.5.1. U.S.
      • 6.5.1.1. By Type
    • 6.5.2. Canada
      • 6.5.2.1. By Type

7. Europe Spirometer Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product Type
    • 7.1.1. Devices
    • 7.1.2. Software
    • 7.1.3. Accessories & Consumables
  • 7.2. Market Analysis, Insights and Forecast - By Type
    • 7.2.1. Volume Measurement
    • 7.2.2. Peak Flow Meters
  • 7.3. Market Analysis, Insights and Forecast - By Application
    • 7.3.1. Chronic Obstructive Pulmonary Disorder (COPD)
    • 7.3.2. Asthma
    • 7.3.3. Others
  • 7.4. Market Analysis, Insights and Forecast - By End User
    • 7.4.1. Hospitals
    • 7.4.2. Diagnostic Centers
    • 7.4.3. Homecare Settings
    • 7.4.4. Physician/Primary Care Offices or Clinics
    • 7.4.5. Other Facilities
  • 7.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.5.1. U.K.
      • 7.5.1.1. By Type
    • 7.5.2. Germany
      • 7.5.2.1. By Type
    • 7.5.3. France
      • 7.5.3.1. By Type
    • 7.5.4. Italy
      • 7.5.4.1. By Type
    • 7.5.5. Spain
      • 7.5.5.1. By Type
    • 7.5.6. Scandinavia
      • 7.5.6.1. By Type
    • 7.5.7. Rest of Europe
      • 7.5.7.1. By Type

8. Asia Pacific Spirometer Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Product Type
    • 8.1.1. Devices
    • 8.1.2. Software
    • 8.1.3. Accessories & Consumables
  • 8.2. Market Analysis, Insights and Forecast - By Type
    • 8.2.1. Volume Measurement
    • 8.2.2. Peak Flow Meters
  • 8.3. Market Analysis, Insights and Forecast - By Application
    • 8.3.1. Chronic Obstructive Pulmonary Disorder (COPD)
    • 8.3.2. Asthma
    • 8.3.3. Others
  • 8.4. Market Analysis, Insights and Forecast - By End User
    • 8.4.1. Hospitals
    • 8.4.2. Diagnostic Centers
    • 8.4.3. Homecare Settings
    • 8.4.4. Physician/Primary Care Offices or Clinics
    • 8.4.5. Other Facilities
  • 8.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.5.1. Japan
      • 8.5.1.1. By Type
    • 8.5.2. China
      • 8.5.2.1. By Type
    • 8.5.3. India
      • 8.5.3.1. By Type
    • 8.5.4. Australia
      • 8.5.4.1. By Type
    • 8.5.5. Southeast Asia
      • 8.5.5.1. By Type
    • 8.5.6. Rest of Asia Pacific
      • 8.5.6.1. By Type

9. Latin America Spirometer Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product Type
    • 9.1.1. Devices
    • 9.1.2. Software
    • 9.1.3. Accessories & Consumables
  • 9.2. Market Analysis, Insights and Forecast - By Type
    • 9.2.1. Volume Measurement
    • 9.2.2. Peak Flow Meters
  • 9.3. Market Analysis, Insights and Forecast - By Application
    • 9.3.1. Chronic Obstructive Pulmonary Disorder (COPD)
    • 9.3.2. Asthma
    • 9.3.3. Others
  • 9.4. Market Analysis, Insights and Forecast - By End User
    • 9.4.1. Hospitals
    • 9.4.2. Diagnostic Centers
    • 9.4.3. Homecare Settings
    • 9.4.4. Physician/Primary Care Offices or Clinics
    • 9.4.5. Other Facilities
  • 9.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.5.1. Brazil
      • 9.5.1.1. By Type
    • 9.5.2. Mexico
      • 9.5.2.1. By Type
    • 9.5.3. Rest of Latin America
      • 9.5.3.1. By Type

10. Middle East & Africa Spirometer Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Product Type
    • 10.1.1. Devices
    • 10.1.2. Software
    • 10.1.3. Accessories & Consumables
  • 10.2. Market Analysis, Insights and Forecast - By Type
    • 10.2.1. Volume Measurement
    • 10.2.2. Peak Flow Meters
  • 10.3. Market Analysis, Insights and Forecast - By Application
    • 10.3.1. Chronic Obstructive Pulmonary Disorder (COPD)
    • 10.3.2. Asthma
    • 10.3.3. Others
  • 10.4. Market Analysis, Insights and Forecast - By End User
    • 10.4.1. Hospitals
    • 10.4.2. Diagnostic Centers
    • 10.4.3. Homecare Settings
    • 10.4.4. Physician/Primary Care Offices or Clinics
    • 10.4.5. Other Facilities
  • 10.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.5.1. GCC
      • 10.5.1.1. By Type
    • 10.5.2. South Africa
      • 10.5.2.1. By Type
    • 10.5.3. Rest of Middle East & Africa
      • 10.5.3.1. By Type

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. ndd Medizintechnik AG
      • 11.2.1.1. Overview
      • 11.2.1.2. Products & Services
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. COSMED srl
      • 11.2.2.1. Overview
      • 11.2.2.2. Products & Services
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. MGC Diagnostics Corporation
      • 11.2.3.1. Overview
      • 11.2.3.2. Products & Services
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. Morgan Scientific
      • 11.2.4.1. Overview
      • 11.2.4.2. Products & Services
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. Chest M.I., Inc.
      • 11.2.5.1. Overview
      • 11.2.5.2. Products & Services
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. VYAIRE
      • 11.2.6.1. Overview
      • 11.2.6.2. Products & Services
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. Ganshorn Medizin Electronic GmbH
      • 11.2.7.1. Overview
      • 11.2.7.2. Products & Services
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Medical International Research (MIR)
      • 11.2.8.1. Overview
      • 11.2.8.2. Products & Services
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Spirometer Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 2: Global Spirometer Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 3: Global Spirometer Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 4: Global Spirometer Market Revenue (USD million) Forecast, by End User, 2021-2034
  • Table 5: Global Spirometer Market Revenue (USD million) Forecast, by Region, 2021-2034
  • Table 6: North America Spirometer Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 7: North America Spirometer Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 8: North America Spirometer Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 9: North America Spirometer Market Revenue (USD million) Forecast, by End User, 2021-2034
  • Table 10: North America Spirometer Market Revenue (USD million) Forecast, By Country, 2021-2034
  • Table 11: U.S. Spirometer Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 12: Canada Spirometer Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 13: Europe Spirometer Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 14: Europe Spirometer Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 15: Europe Spirometer Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 16: Europe Spirometer Market Revenue (USD million) Forecast, by End User, 2021-2034
  • Table 17: Europe Spirometer Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 18: U.K. Spirometer Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 19: Germany Spirometer Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 20: France Spirometer Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 21: Italy Spirometer Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 22: Spain Spirometer Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 23: Scandinavia Spirometer Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 24: Rest of Europe Spirometer Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 25: Asia Pacific Spirometer Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 26: Asia Pacific Spirometer Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 27: Asia Pacific Spirometer Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 28: Asia Pacific Spirometer Market Revenue (USD million) Forecast, by End User, 2021-2034
  • Table 29: Asia Pacific Spirometer Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 30: Japan Spirometer Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 31: China Spirometer Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 32: India Spirometer Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 33: Australia Spirometer Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 34: Southeast Asia Spirometer Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 35: Rest of Asia Pacific Spirometer Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 36: Latin America Spirometer Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 37: Latin America Spirometer Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 38: Latin America Spirometer Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 39: Latin America Spirometer Market Revenue (USD million) Forecast, by End User, 2021-2034
  • Table 40: Latin America Spirometer Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 41: Brazil Spirometer Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 42: Mexico Spirometer Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 43: Rest of Latin America Spirometer Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 44: Middle East & Africa Spirometer Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 45: Middle East & Africa Spirometer Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 46: Middle East & Africa Spirometer Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 47: Middle East & Africa Spirometer Market Revenue (USD million) Forecast, by End User, 2021-2034
  • Table 48: Middle East & Africa Spirometer Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 49: GCC Spirometer Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 50: South Africa Spirometer Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 51: Rest of Middle East & Africa Spirometer Market Revenue (USD million) Forecast, by Type, 2021-2034

List of Figures

  • Figure 1: Global Spirometer Market Revenue Breakdown (USD million, %) by Region, 2025 & 2034
  • Figure 2: Global Spirometer Market Value Share (%), by Product Type, 2025 & 2034
  • Figure 3: Global Spirometer Market Value Share (%), by Type, 2025 & 2034
  • Figure 4: Global Spirometer Market Value Share (%), by Application, 2025 & 2034
  • Figure 5: Global Spirometer Market Value Share (%), by End User, 2025 & 2034
  • Figure 6: Global Spirometer Market Value (USD million), by Region, 2025 & 2034
  • Figure 7: North America Spirometer Market Value (USD million), by Product Type, 2025 & 2034
  • Figure 8: North America Spirometer Market Value Share (%), by Product Type, 2025
  • Figure 9: North America Spirometer Market Value (USD million), by Type, 2025 & 2034
  • Figure 10: North America Spirometer Market Value Share (%), by Type, 2025
  • Figure 11: North America Spirometer Market Value (USD million), by Application, 2025 & 2034
  • Figure 12: North America Spirometer Market Value Share (%), by Application, 2025
  • Figure 13: North America Spirometer Market Value (USD million), by End User, 2025 & 2034
  • Figure 14: North America Spirometer Market Value Share (%), by End User, 2025
  • Figure 15: North America Spirometer Market Value (USD million), By Country, 2025 & 2034
  • Figure 16: North America Spirometer Market Value Share (%), By Country, 2025
  • Figure 17: Europe Spirometer Market Value (USD million), by Product Type, 2025 & 2034
  • Figure 18: Europe Spirometer Market Value Share (%), by Product Type, 2025
  • Figure 19: Europe Spirometer Market Value (USD million), by Type, 2025 & 2034
  • Figure 20: Europe Spirometer Market Value Share (%), by Type, 2025
  • Figure 21: Europe Spirometer Market Value (USD million), by Application, 2025 & 2034
  • Figure 22: Europe Spirometer Market Value Share (%), by Application, 2025
  • Figure 23: Europe Spirometer Market Value (USD million), by End User, 2025 & 2034
  • Figure 24: Europe Spirometer Market Value Share (%), by End User, 2025
  • Figure 25: Europe Spirometer Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 26: Europe Spirometer Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 27: Asia Pacific Spirometer Market Value (USD million), by Product Type, 2025 & 2034
  • Figure 28: Asia Pacific Spirometer Market Value Share (%), by Product Type, 2025
  • Figure 29: Asia Pacific Spirometer Market Value (USD million), by Type, 2025 & 2034
  • Figure 30: Asia Pacific Spirometer Market Value Share (%), by Type, 2025
  • Figure 31: Asia Pacific Spirometer Market Value (USD million), by Application, 2025 & 2034
  • Figure 32: Asia Pacific Spirometer Market Value Share (%), by Application, 2025
  • Figure 33: Asia Pacific Spirometer Market Value (USD million), by End User, 2025 & 2034
  • Figure 34: Asia Pacific Spirometer Market Value Share (%), by End User, 2025
  • Figure 35: Asia Pacific Spirometer Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 36: Asia Pacific Spirometer Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 37: Latin America Spirometer Market Value (USD million), by Product Type, 2025 & 2034
  • Figure 38: Latin America Spirometer Market Value Share (%), by Product Type, 2025
  • Figure 39: Latin America Spirometer Market Value (USD million), by Type, 2025 & 2034
  • Figure 40: Latin America Spirometer Market Value Share (%), by Type, 2025
  • Figure 41: Latin America Spirometer Market Value (USD million), by Application, 2025 & 2034
  • Figure 42: Latin America Spirometer Market Value Share (%), by Application, 2025
  • Figure 43: Latin America Spirometer Market Value (USD million), by End User, 2025 & 2034
  • Figure 44: Latin America Spirometer Market Value Share (%), by End User, 2025
  • Figure 45: Latin America Spirometer Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 46: Latin America Spirometer Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 47: Middle East & Africa Spirometer Market Value (USD million), by Product Type, 2025 & 2034
  • Figure 48: Middle East & Africa Spirometer Market Value Share (%), by Product Type, 2025
  • Figure 49: Middle East & Africa Spirometer Market Value (USD million), by Type, 2025 & 2034
  • Figure 50: Middle East & Africa Spirometer Market Value Share (%), by Type, 2025
  • Figure 51: Middle East & Africa Spirometer Market Value (USD million), by Application, 2025 & 2034
  • Figure 52: Middle East & Africa Spirometer Market Value Share (%), by Application, 2025
  • Figure 53: Middle East & Africa Spirometer Market Value (USD million), by End User, 2025 & 2034
  • Figure 54: Middle East & Africa Spirometer Market Value Share (%), by End User, 2025
  • Figure 55: Middle East & Africa Spirometer Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 56: Middle East & Africa Spirometer Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 57: Global Spirometer Market Share (%), By Company, 2025